Form 4 Tracker
PRECISION BIOSCIENCES INC
DTIL

25 insider filings · Latest: Sep 28, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 28, 2026Sep 30 8:15 PMStanley FrankelDirector
Purchase
1,000$6.00$6.0K41,478(D)

View →

Sep 25, 2026Sep 29 11:00 AMMelinda BrownDirector
Purchase
1,135$6.27$7.1K45,481(D)

View →

Sep 25, 2026Sep 29 11:00 AMGeno J GermanoDirector
Purchase
2,609$6.28$16.4K47,492(D)

View →

Feb 18, 2026Feb 19 9:31 PMMichael AmorosoDirector, President and CEO
Sale
20,559$3.84$78.9K243,392(D)

View →

Feb 18, 2026Feb 19 9:31 PMJohn Alexander KellyChief Financial Officer
Sale
8,149$3.84$31.3K125,883(D)

View →

Feb 18, 2026Feb 19 9:30 PMDario ScimecaGeneral Counsel and Secretary
Sale
4,925$3.84$18.9K56,457(D)

View →

Feb 18, 2026Feb 19 9:30 PMJefferson J. SmithChief Research Officer
Sale
4,925$3.84$18.9K121,926(D)

View →

Feb 18, 2026Feb 18 10:05 PMSMITH J. JEFFERSON
Proposed Sale
4,925$3.84$18.9K—

View →

Feb 18, 2026Feb 18 9:31 PMScimeca Dario
Proposed Sale
4,925$3.84$18.9K—

View →

Feb 18, 2026Feb 18 9:30 PMAmoroso Michael
Proposed Sale
20,559$3.84$79.0K—

View →

Feb 18, 2026Feb 18 9:19 PMKelly John Alexander
Proposed Sale
8,149$3.84$31.3K—

View →

Jan 22, 2026Jan 22 11:49 PMMichael AmorosoDirector, President and CEO
Sale
34,799$4.17$145.1K196,154(D)

View →

Jan 21, 2026Jan 22 11:48 PMDario ScimecaGeneral Counsel and Secretary
Sale
8,854$4.03$35.7K44,715(D)

View →

Jan 21, 2026Jan 22 11:48 PMJohn Alexander KellyChief Financial Officer
Sale
15,213$4.03$61.3K106,448(D)

View →

Jan 21, 2026Jan 22 11:48 PMJefferson J. SmithChief Research Officer
Sale
10,200$4.03$41.1K110,184(D)

View →

Jan 22, 2026Jan 22 8:19 PMAmoroso Michael
Proposed Sale
34,799$4.17$145.2K—

View →

Jan 21, 2026Jan 21 9:19 PMScimeca Dario
Proposed Sale
8,854$4.03$35.7K—

View →

Jan 21, 2026Jan 21 9:14 PMSMITH J. JEFFERSON
Proposed Sale
10,200$4.03$41.1K—

View →

Jan 21, 2026Jan 21 9:07 PMKelly John Alexander
Proposed Sale
15,213$4.03$61.3K—

View →

Nov 3, 2025Nov 3 8:16 PMKelly John Alexander
Proposed Sale
1,303$6.49$8.5K—

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 20, 2026Jan 22 11:48 PMJohn Alexander KellyChief Financial Officer
Option Exercise
44,363—26,575(D)

View →

Jan 20, 2026Jan 22 11:48 PMJefferson J. SmithChief Research Officer
Option Exercise
29,166—16,219(D)

View →

← Previous

Page 2 of 2